Last reviewed · How we verify

Prednisone+vincristine+Mercaptopurine

Shanghai Children's Medical Center · Phase 3 active Small molecule

Prednisone+vincristine+Mercaptopurine is a Corticosteroid, Vinca alkaloid, Purine antagonist Small molecule drug developed by Shanghai Children's Medical Center. It is currently in Phase 3 development for Acute lymphoblastic leukemia.

Prednisone is a corticosteroid that suppresses the immune system, vincristine is a vinca alkaloid that inhibits microtubule formation, and mercaptopurine is a purine antagonist that interferes with DNA synthesis.

Prednisone is a corticosteroid that suppresses the immune system, vincristine is a vinca alkaloid that inhibits microtubule formation, and mercaptopurine is a purine antagonist that interferes with DNA synthesis. Used for Acute lymphoblastic leukemia.

At a glance

Generic namePrednisone+vincristine+Mercaptopurine
SponsorShanghai Children's Medical Center
Drug classCorticosteroid, Vinca alkaloid, Purine antagonist
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 3

Mechanism of action

Prednisone works by inhibiting the production of inflammatory cytokines, while vincristine prevents the formation of microtubules necessary for cell division, leading to cell cycle arrest. Mercaptopurine, on the other hand, is metabolized into its active form, which then inhibits xanthine oxidase and interferes with DNA synthesis, ultimately leading to cell death.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Prednisone+vincristine+Mercaptopurine

What is Prednisone+vincristine+Mercaptopurine?

Prednisone+vincristine+Mercaptopurine is a Corticosteroid, Vinca alkaloid, Purine antagonist drug developed by Shanghai Children's Medical Center, indicated for Acute lymphoblastic leukemia.

How does Prednisone+vincristine+Mercaptopurine work?

Prednisone is a corticosteroid that suppresses the immune system, vincristine is a vinca alkaloid that inhibits microtubule formation, and mercaptopurine is a purine antagonist that interferes with DNA synthesis.

What is Prednisone+vincristine+Mercaptopurine used for?

Prednisone+vincristine+Mercaptopurine is indicated for Acute lymphoblastic leukemia.

Who makes Prednisone+vincristine+Mercaptopurine?

Prednisone+vincristine+Mercaptopurine is developed by Shanghai Children's Medical Center (see full Shanghai Children's Medical Center pipeline at /company/shanghai-children-s-medical-center).

What drug class is Prednisone+vincristine+Mercaptopurine in?

Prednisone+vincristine+Mercaptopurine belongs to the Corticosteroid, Vinca alkaloid, Purine antagonist class. See all Corticosteroid, Vinca alkaloid, Purine antagonist drugs at /class/corticosteroid-vinca-alkaloid-purine-antagonist.

What development phase is Prednisone+vincristine+Mercaptopurine in?

Prednisone+vincristine+Mercaptopurine is in Phase 3.

What are the side effects of Prednisone+vincristine+Mercaptopurine?

Common side effects of Prednisone+vincristine+Mercaptopurine include Nausea, Vomiting, Diarrhea, Hair loss, Fatigue.

Related